Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tomás Guillardoy"'
Autor:
Lucía Saucedo, Gabriela N Buffa, Marina Rosso, Tomás Guillardoy, Adrian Góngora, María J Munuce, Mónica H Vazquez-Levin, Clara Marín-Briggiler
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127297 (2015)
Fibroblast growth factors receptors (FGFRs) have been widely characterized in somatic cells, but there is scarce evidence of their expression and function in mammalian gametes. The objective of the present study was to evaluate the expression of FGFR
Externí odkaz:
https://doaj.org/article/cc73074e172642acb2da9e5d42cf6c73
Autor:
Claudia Lanari, Caroline A. Lamb, Eduardo Zeitlin, Rubén Martins, Silvia I. Vanzulli, J. Silvio Gutkind, José P. Vaque, Sebastián Giulianelli, Tomás Guillardoy, Juan P. Cerliani
Supplementary Figures 1-5 from Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2fc41308c0a1d18a98be842b826625
https://doi.org/10.1158/0008-5472.22388814
https://doi.org/10.1158/0008-5472.22388814
Autor:
Claudia Lanari, Caroline A. Lamb, Eduardo Zeitlin, Rubén Martins, Silvia I. Vanzulli, J. Silvio Gutkind, José P. Vaque, Sebastián Giulianelli, Tomás Guillardoy, Juan P. Cerliani
Supplementary Table 1 from Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef8fe9e7faf51f5aa25bfb79ac37113
https://doi.org/10.1158/0008-5472.22388811.v1
https://doi.org/10.1158/0008-5472.22388811.v1
Autor:
Martín Carlos Abba, María Florencia Toledo, Sebastián Giulianelli, Cecilia Pérez Piñero, Fátima Liliana Monteiro, Tomás Guillardoy, Britta M. Jacobsen, Gonzalo Ricardo Sequeira, António Barros, Gabriela Pataccini, Hugo Gass, Luisa A. Helguero, Claudia Lanari, Francisco Amado, María Florencia Abascal, Virginia Novaro, Ana Guerreiro, Marina Riggio, Maria Alicia Gorostiaga
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Progression to hormone-independent growth leading to endocrine therapy resistance occurs in a high proportion of patients with estrogen receptor alpha (ERα) and progesterone receptors (PR) positive breast cancer. We and others have previously shown
Autor:
Tomás Guillardoy, María José Munuce, Mónica H. Vazquez-Levin, Marina Rosso, Adrian Góngora, Clara I. Marín-Briggiler, Lucía Saucedo, Gabriela N. Buffa
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127297 (2015)
PLoS ONE
PLoS ONE
Fibroblast growth factors receptors (FGFRs) have been widely characterized in somatic cells, but there is scarce evidence of their expression and function in mammalian gametes. The objective of the present study was to evaluate the expression of FGFR
Autor:
Claudia Lanari, J. Silvio Gutkind, Silvia Vanzulli, Caroline A. Lamb, José P. Vaqué, Sebastián Giulianelli, Juan P. Cerliani, Eduardo Zeitlin, Rubén Martins, Tomás Guillardoy
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Fibroblast growth factor (FGF) receptor 2 (FGFR-2) polymorphisms have been associated with an increase in estrogen receptor and progesterone receptor (PR)-positive breast cancer risk; however, a clear mechanistic association between FGFR-2 and steroi
Publikováno v:
Molecular Cancer Research. 11:A006-A006
Estrogen and progesterone receptors (ER and PR respectively) are prognostic markers and dictate therapeutic decisions in breast cancer patients. Although most of the evidence suggests that estrogens are the major etiological factors in breast cancer,
Publikováno v:
Cancer Research. 73:532-532
Fibroblast growth factor (FGF) receptors (FGFRs) are dysregulated in a number of developmental and neoplastic conditions. In human breast cancer samples we have previously demonstrated a significant association between FGFR2 expression and estrogen r
Publikováno v:
Cancer Research. 71:3353-3353
It has been postulated that breast cancer stem cells (CSC) or progenitor cells express low levels of hormone receptors. Mouse mammary carcinomas induced by medroxyprogesterone acetate (MPA) are maintained by syngeneic transplantation and tumor varian
Publikováno v:
Cancer Research. 70:3170-3170
We have developed a murine model of breast cancer in which hormone-dependent (HD) carcinomas transit through different stages of hormone responsiveness retaining the expression of estrogen and progesterone receptors (PR). Unlike HD carcinomas, hormon